Breast Lesion Localization Market
                     Breast Lesion Localization Market
Global Forecast to 2026
Breast Lesion Localization 
Market is expected to reach 
$ 305 Million by 2026
Growing at a 
CAGR of  4.6% (2021 – 2026)
                                                                                                                          
The breast lesion localization market is expected to reach USD 305 million 
by 2026 from USD 244 million in 2021, will grow at a CAGR of 4.6% during 
the forecast period.
The growth of this market is mainly attributed to the growing incidence of 
breast cancer, the increasing rate of the geriatric population (as age 
contributes to the risk of breast cancer), the rising awareness on the early 
detection of breast cancer in the coming years and improved reimbursement 
scenario. However, several factors, such as errors in screening alongside 
misdiagnosis and uncertainty in regulatory approval procedures are 
expected to restrain the growth of the breast lesion localization market during 
the forecast period.
Hologic is a leading player in the global breast lesion localization methods market. The 
broad portfolio of breast lesion localization products is a major factor responsible for its 
large share in this market. The company focuses on both organic and inorganic growth 
strategies to enhance its footprint in the global market. Additionally, over the last few 
years, Hologic has strengthened its customer base and expanded its product portfolio 
through inorganic growth strategies, such as acquisitions and partnerships. With its 
strong product portfolio and wide geographic presence, Hologic is expected to witness 
significant growth in the breast lesion localization market during the forecast period.
Becton, Dickinson and Company (BD) is the second leading player in the breast lesion 
localization market. Through its Medication Delivery Solutions segment, the company 
offers wire and radio-guided localization devices in the breast surgery market. The 
company has acquired a product line of localization wires and devices to enhance its 
presence in this market. The company now focuses upon R&D to introduce newer and 
technologically sound products in the breast lesion localization market. The company 
marks footprints in various countries across the globe.